Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells.
about
Characterization of rhodamine-123 as a tracer dye for use in in vitro drug transport assaysClinical Implications of P-Glycoprotein Modulation in Drug-Drug Interactions.Dual approach utilizing self microemulsifying technique and novel P-gp inhibitor for effective delivery of taxanes.Characterization of rhodamine self-assembled films using desorption electrospray ionization mass spectrometry.Transport inhibition of digoxin using several common P-gp expressing cell lines is not necessarily reporting only on inhibitor binding to P-gp.Rhodamine inhibitors of P-glycoprotein: an amide/thioamide "switch" for ATPase activity.Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.Thiomer-coated liposomes harbor permeation enhancing and efflux pump inhibitory properties.Population-based mechanistic prediction of oral drug absorptionPolyoxyethylene 40 stearate modulates multidrug resistance and enhances antitumor activity of vinblastine sulfate.Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer.Thiomers: promising platform for macromolecular drug delivery.Pharmacokinetic evaluation of C-3 modified 1,8-naphthyridine-3-carboxamide derivatives with potent anticancer activity: lead finding.The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2.Thiorhodamines containing amide and thioamide functionality as inhibitors of the ATP-binding cassette drug transporter P-glycoprotein (ABCB1).Effect of HEPES buffer on the uptake and transport of P-glycoprotein substrates and large neutral amino acids.Salmonella enterica serovar Typhimurium modulates P-glycoprotein in the intestinal epithelium.Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function In Vitro.Effects of nonsteroidal anti-inflammatory drugs on the expression and function of P-glycoprotein/MDR1 in Caco-2 cells.The effect of P-glycoprotein on methadone hydrochloride flux in equine intestinal mucosa.Modulating effect of polyethylene glycol on the intestinal transport and absorption of prednisolone, methylprednisolone and quinidine in rats by in-vitro and in-situ absorption studies.Selamectin is a potent substrate and inhibitor of human and canine P-glycoprotein.Effect of pluronic P123 and F127 block copolymer on P-glycoprotein transport and CYP3A metabolism.A Fluorescent Probe for Neural Stem/Progenitor Cells with High Differentiation Capability into Neurons.Intestinal Permeability of β-Lapachone and Its Cyclodextrin Complexes and Physical Mixtures.Kinetic considerations for the quantitative assessment of efflux activity and inhibition: implications for understanding and predicting the effects of efflux inhibition.Expression and functional activity of P-glycoprotein in passaged primary human nasal epithelial cell monolayers cultured by the air-liquid interface method for nasal drug transport study.A multi-chamber microfluidic intestinal barrier model using Caco-2 cells for drug transport studies.Using Human Plasma as an Assay Medium in Caco-2 Studies Improves Mass Balance for Lipophilic Compounds
P2860
Q28481706-83E147C4-FE58-43A3-8875-A2F8F933EF14Q30234940-FFCB11E1-AF60-459D-B540-3C3BB5E21C9CQ34206944-A03C2918-4AB9-4B97-B931-9EFCAF286137Q34655910-C9125A11-711A-45AF-BE05-49576258A517Q34970234-FE201426-AFE7-4100-AEF1-F5C1CA9CBE32Q36103906-CB0B5C8B-0FA0-4DC2-BDC6-8FF43706093BQ36371642-9760CC6B-C07F-4E06-AA60-B1790DAC9D4AQ36575250-59338CC0-F634-47F9-9E56-D63C7B834DA7Q37214520-B4043705-DA61-4A4E-AEC7-882928C4D7A9Q37361981-CA6612AB-E38A-4EC1-95DE-4D435E8636E7Q37740126-F39F6184-FDEB-4BA3-B6AD-09F27C3773BFQ38063302-46211CA0-9815-4091-99F2-BAAA78081AF7Q39071253-724D9DA5-34D0-4B3D-A406-238D16B95B8FQ39293014-8D30738D-1431-4C24-86CC-E6DCDEBAD6CDQ39326387-878672A6-A5E5-45D0-A3F7-365FEB17B40CQ39738295-1DA0D9B7-2927-47CB-9F8F-3C88D17E3E19Q39993149-0DD0C75D-968B-4DBC-9FB5-622367473DA3Q40052643-74F1FB1E-AC16-43F2-B5DC-E29825D48BC2Q43269139-1E791E72-DFBF-4EB8-B9DB-F7851612503CQ43943908-F4A677CE-65ED-4B11-B659-E6EF146A48F3Q46253927-ED11A05F-0888-45ED-8897-18390EAFB206Q46543591-44A4D2ED-4EFF-42CD-9650-EF56D2DC77E5Q48215029-B0F8FBBB-CA62-4728-8A05-655A3C63360FQ48458614-D9022F0A-3095-4540-BE71-C7B990B494BFQ51631401-A27686C8-C322-4A1E-8668-C31E61B4F5D6Q51926084-00930BD4-B846-48FE-BDBB-86ACCBAF6CE6Q54359974-813CD7EE-C927-4DDE-9B62-6C2BEFF8667EQ55012853-178AFF65-9BBC-4B76-97F9-8DDED6B4F4CEQ58731266-6E5D424F-A9DD-490B-9E33-24EB093CABB9
P2860
Rhodamine 123 requires carrier-mediated influx for its activity as a P-glycoprotein substrate in Caco-2 cells.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Rhodamine 123 requires carrier ...... ein substrate in Caco-2 cells.
@ast
Rhodamine 123 requires carrier ...... ein substrate in Caco-2 cells.
@en
type
label
Rhodamine 123 requires carrier ...... ein substrate in Caco-2 cells.
@ast
Rhodamine 123 requires carrier ...... ein substrate in Caco-2 cells.
@en
prefLabel
Rhodamine 123 requires carrier ...... ein substrate in Caco-2 cells.
@ast
Rhodamine 123 requires carrier ...... ein substrate in Caco-2 cells.
@en
P356
P1476
Rhodamine 123 requires carrier ...... ein substrate in Caco-2 cells.
@en
P2093
Dhiren R Thakker
Matthew D Troutman
P304
P356
10.1023/A:1025096930604
P577
2003-08-01T00:00:00Z